|
| 35973593 | Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial. | Ophthalmology | 2023 |
| 37081576 | The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degeneration. | Pilot Feasibility Stud | 2023 |
| 36449258 | Correction to: Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis. | Adv Ther | 2023 |
| 35314774 | The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice. | Eye (Lond) | 2022 |
| 36541393 | Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT. | Health Technol Assess | 2022 |
| 36250165 | Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation study. | Frontline Gastroenterol | 2022 |
| 35995894 | Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis. | Adv Ther | 2022 |
| 34329651 | Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study. | Ophthalmology | 2021 |
| 33840064 | Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion. | Ophthalmol Ther | 2021 |
| 33753379 | Management of Crohn's disease in an immunosuppressed COVID-19-positive patient: safety-driven prioritisation of nutritional therapy as a bridge to restarting immunosuppression. | BMJ Case Rep | 2021 |
| 34192155 | Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era. | BMJ Open Ophthalmol | 2021 |
| 32144084 | Progression from Early/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors. | Ophthalmol Retina | 2020 |
| 31900438 | Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration. | Eye (Lond) | 2020 |
| 33187976 | High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning. | BMJ Open Gastroenterol | 2020 |
| 33214234 | Life in lockdown: experiences of patients with IBD during COVID-19. | BMJ Open Gastroenterol | 2020 |
| 32699378 | Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group. | Eye (Lond) | 2020 |
| 32504038 | Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group. | Eye (Lond) | 2020 |
| 32546938 | Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service Delivery. | Clin Ophthalmol | 2020 |
| 30676615 | Secondary End Points in the RIVAL Study. | JAMA Ophthalmol | 2019 |
| 32133109 | Early real-world effectiveness of ustekinumab for Crohn's disease. | Frontline Gastroenterol | 2019 |
| 31416764 | Direct Ophthalmic Healthcare Resource Use among Patients with Geographic Atrophy in a Large Cohort from the United Kingdom. | Ophthalmol Retina | 2019 |
| 31179389 | Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema. | BMJ Open Ophthalmol | 2019 |
| 30926932 | Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service. | Eye (Lond) | 2019 |
| 30728488 | Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab. | Eye (Lond) | 2019 |
| 30755274 | Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial. | Trials | 2019 |
| 30269098 | United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services. | Br J Ophthalmol | 2019 |
| 29366564 | Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration. | Ophthalmology | 2018 |
| 30237693 | Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group. | Clin Ophthalmol | 2018 |
| 28257378 | CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA. | Retina | 2018 |
| 28406859 | VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED. | Retina | 2018 |
| 27965262 | The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema. | Br J Ophthalmol | 2017 |
| 28487377 | The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema. | Br J Ophthalmol | 2017 |
| 28130330 | Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme. | J Crohns Colitis | 2017 |
| 28478396 | UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice. | Br J Ophthalmol | 2017 |
| 28572062 | The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy. | Am J Ophthalmol | 2017 |
| 28508241 | Resource Use and Real-World Outcomes for Ranibizumab Treat and Extend for Neovascular Age-Related Macular Degeneration in the UK: Interim Results from TERRA. | Ophthalmol Ther | 2017 |
| 28575650 | Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR. | Am J Hum Genet | 2017 |
| 26768921 | The design and validation of an optical coherence tomography-based classification system for focal vitreomacular traction. | Eye (Lond) | 2016 |
| 28863275 | Mutations in TSPAN12 Cause Autosomal-Dominant Familial Exudative Vitreoretinopathy. | Am J Hum Genet | 2016 |
| 27419839 | The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care. | Eye (Lond) | 2016 |
| 25680619 | UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12. | Br J Ophthalmol | 2015 |
| 26126503 | Patient attitudes towards prenatal diagnostic testing for inherited retinal disease. | Prenat Diagn | 2015 |
| 26150052 | Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study. | Ophthalmology | 2015 |
| 24398793 | Current understanding of genetics and genetic testing and information needs and preferences of adults with inherited retinal disease. | Eur J Hum Genet | 2014 |
| 24953791 | The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes. | Ophthalmology | 2014 |
| 23813418 | Understanding of and attitudes to genetic testing for inherited retinal disease: a patient perspective. | Br J Ophthalmol | 2013 |
| 22427576 | Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR). | Invest Ophthalmol Vis Sci | 2012 |
| 22241016 | Combined OCT and colour fundus photography in virtual clinic assessments of wet AMD patients. | Eye (Lond) | 2012 |
| 19911016 | Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration. | Eye (Lond) | 2010 |
| 20159112 | Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. | Am J Hum Genet | 2010 |